Fiche du document
- doi: 10.1086/597006
- issn: 1058-4838
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1086/597006
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/19191654
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1537-6591
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_E6BF21E87E7A0
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Communicable diseases--Vaccination Preventive inoculation Inoculation Preventive inoculation Diseases--VaccinationCiter ce document
O. Veit et al., « Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients. », Serveur académique Lausannois, ID : 10.1086/597006
Métriques
Partage / Export
Résumé
BACKGROUND: Yellow fever vaccine (17DV) has been investigated incompletely in human immunodeficiency virus (HIV)-infected patients, and adequate immunogenicity and safety are of concern in this population. METHODS: In the Swiss HIV Cohort Study, we identified 102 patients who received 17DV while they were HIV infected. We analyzed neutralization titers (NTs) after 17DV administration using the plaque reduction neutralization test. NTs of 1:>or=10 were defined as reactive, and those of 1: